Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/49706
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWisanu Maneeraten_US
dc.contributor.authorThunwadee Ritthiwigromen_US
dc.contributor.authorSarot Cheenprachaen_US
dc.contributor.authorUma Prawaten_US
dc.contributor.authorSurat Laphookhieoen_US
dc.date.accessioned2018-09-04T04:05:48Z-
dc.date.available2018-09-04T04:05:48Z-
dc.date.issued2011-06-29en_US
dc.identifier.issn18733581en_US
dc.identifier.issn00404039en_US
dc.identifier.other2-s2.0-79957607206en_US
dc.identifier.other10.1016/j.tetlet.2011.04.064en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79957607206&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/49706-
dc.description.abstractTwo new dimeric carbazole alkaloids, clausenawallines A and B, were isolated from the roots of Clausena wallichii. Their structures were elucidated by spectroscopic methods. Clausenawalline A was evaluated for its biological activities [anti-malaria (IC502.46 μg/mL), anti-TB (MIC 12.50 μg/mL)] and cytotoxicity against three human cancer cell lines [KB (IC507.87 μg/mL), MCF7 (IC5025.43 μg/mL), and NCI-H187 (IC5010.97 μg/mL)]. © 2011 Elsevier Ltd. All rights reserved.en_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectChemistryen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleClausenawallines A and B, two new dimeric carbazole alkaloids from the roots of Clausena wallichiien_US
dc.typeJournalen_US
article.title.sourcetitleTetrahedron Lettersen_US
article.volume52en_US
article.stream.affiliationsMae Fah Luang Universityen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsUniversity of Phayaoen_US
article.stream.affiliationsPhuket Rajabhat Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.